Ultomiris as Shorter Infusion Approved in Europe to Treat aHUS
News
The European Commission has approved a new intravenous formulation of Ultomiris (ravulizumab) to treat for adults and children with atypical hemolytic uremic syndrome (aHUS) that allows the medication to be ... Read more